Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon May 25, 2018 4:10pm

156 Views

Post# 28082542

RE:just sent an E-mail...

FredTheVoice wrote:
Just sent an E-mail at TMX; could someone explain to me why they post a 4,96$ 52 year LOW, when the reality is more than 6$ ?

Good week for TH.

Good weekend to all.

FTV.

Hi Fred,

The stock traded under $5 in November 2017 when the FDA delay news was released.

I remember it distinctly as I picked up some more shares that day.

bfw

Bullboard Posts

Calibre discovers significant gold in Newfoundland